Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: This is a one page report with limited details provided. However, the results serve to indicate the low toxicity of the test substance.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1982
Report date:
1982

Materials and methods

Test guideline
Guideline:
other: In house method G.2.2.1.
Principles of method if other than guideline:
5 groups of male Sprague Dawley rats were given a single dose of DEFI (20% concentration) on day 1 doses of 3.3, 4.1, 5.1, 6.4 and 8.0 g/kg. Animals were observed for mortality and clinical signs on days 1, 2, 3, 4, 7 and 14, with bodyweight measured on days 0, 7 and 14.
GLP compliance:
no
Test type:
standard acute method

Test material

Constituent 1
Reference substance name:
Fatty acids, coco, 2-sulfoethyl esters, sodium salts
EC Number:
263-052-5
EC Name:
Fatty acids, coco, 2-sulfoethyl esters, sodium salts
Cas Number:
61789-32-0
Molecular formula:
C10H20O5S.Na-C20H40O5S.Na
IUPAC Name:
Fatty acids, coco, 2-sulfoethyl esters, sodium salts
Details on test material:
- Name of test material:Directly Esterified Fatty Isethionate (DEFI) identified by Unilever as a 20% concentration (Sodium cocoyl isethionate).

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 170-201g

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 20%
- Amount of vehicle: not reported
Doses:
Single doses of 3.3, 4.1, 5.1, 6.4 and 8.0 g/kg
No. of animals per sex per dose:
5
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for mortality and other overt signs on days 1, 2, 3, 4, 7, and 14. Body weights were measured on days 0, 7 and 14.
- Necropsy of survivors performed: yes
Statistics:
Probit (E1-2)

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
8 400 mg/kg bw
Mortality:
Mortalities were observed in the two highest dose groups only. In the 8 g/kg group, 2 animals died on day 1 and 1 on day 2. In the 6.4 g/kg group one animal died on day 4.
Clinical signs:
Slight diarrhea was observed in two animals in the 4.1 g/kg dose within 1-2 hours after dosing. Moderate diarrhea was observed in two, four and five animals about 1 hour after dosing in the 5.1, 6.4, and 8.0 g/kg bw doses, respectively. Lethargy was observed in all 8.0 g/kg dose animals 1 hour after dosing. Some lethargy was also observed at about 22 hours in a single animal each at the 6.4 and 8.0 doses
Body weight:
No significant effects to body weight were observed.
Gross pathology:
Gross pathology at necropsy revealed no significant findings.
Moderate inflammation of the gastric mucosa was observed in the animals that died on day 1 and 2 in the 8.0 g/kg bw dose.

Any other information on results incl. tables

Mortalities were observed in the two highest dose groups only.   In the 8 g/kg group, 2 animals died on day 1 and 1 on day 2.  In the 6.4 mg/kg group one animal died on day 4.

Clinical signs were observed in all dose groups except the lowest (3.1 g/kg).  

Lethargy was observed in all 8 mg/kg dose group animals approximately 1 hour after dosing.  Some lethargy was also observed at about 22 hours in a single animal each at the 6.4 and 8.0 g/kg doses.

Diarrhoea was observed in the 4.1, 5.1, 6.4 and 8 g/kg dose groups.  Moderate diarrhoea was observed in two, four and five animals about 1 hour after dosing in the 5.1, 6.4, and 8.0 g/kg bw doses, respectively. Slight diarrhoea was observed in two animals in the 4.1 g/kg dose within 1-2 hours after dosing.

Applicant's summary and conclusion

Interpretation of results:
relatively harmless
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
In an acute oral toxicity study performed similar to current guidelines the SCI is considered to be of low toxicity, with a LD50 of 8.4 g/kg.